Facebook Pixel {العنوان: سلسلة} | {اسم المغناطيس: سلسلة} - {الفئة: سلسلة} - اقرأ هذه القصة على Magzter.com
استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

3D printing moulds healthcare innovations

September 2021

|

Bio Spectrum

Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.

- Prabhat Prakash

3D printing moulds healthcare innovations

3D printing has made tremendous contributions throughout healthcare. It has been able to improve clinical outcomes, reduce operation duration and also reduce overall treatment cost. 3D printing has been serving major applications across the globe such as replacing human organ transplants, producing cheaper versions of required surgical tools, speeding up surgical procedures, and improving the lives of patients on prosthetic limbs. Newer tools, advanced technologies are helping in delivering better treatments and devices that are customised to better serve the patient.

As per a recent report by Markets and Research, the global automated 3D printing market was valued at $507.8 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of around 37.14 per cent over the forecast period (2021 - 2026). Although the additive printing market has witnessed growth in India as well, there is still a lot of untapped potential.

Policy standardisation

Despite the potential of 3D printing technology, there is no global policy on the same. Globally industries are looking at 3D printing technology as the technology of the future, governments need to take this into account and try and regulate the sector as and when the need arises. It would be helpful as different countries currently are in different phases of 3D printing technology adoption across industries. For instance, in 2018, China issued guidelines for regulation and registration of 3D printed medical devices which included custom-built additive produced medical devices. China further issued several guidelines for different 3D printed medical devices including a 2020 technical guidance for 3D printed artificial vertebrae and acetabular cups.

المزيد من القصص من Bio Spectrum

Bio Spectrum

Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing

Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

NATHEALTH names Dr Sangita Reddy as new President

NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.

time to read

1 min

May 2026

Bio Spectrum

Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap

In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.

time to read

7 mins

May 2026

Bio Spectrum

WHO lays focus on simulation exercises to strengthen health emergency readiness

To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Akrivia Biosciences decodes breast cancer genomic heterogeneity

Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Integrating AI for Tech-driven Ayurveda

A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.

time to read

2 mins

May 2026

Bio Spectrum

ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation

ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.

time to read

1 min

May 2026

Bio Spectrum

MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students

MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Thermo Fisher launches integrated platform to accelerate biologics development

Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay

Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.

time to read

1 min

May 2026

Translate

Share

-
+

Change font size